furosemide has been researched along with perindopril in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Leary, WP; Reyes, AJ; Van der Byl, K | 1 |
| Auzan, C; Choudat, L; Corvol, P; Dussaule, JC; Menard, J; Michel, JB; Nochy, D | 1 |
| Alhenc-Gélas, F; Auzan, C; Corvol, P; Dussaule, JC; Ménard, J; Michel, JB | 1 |
| Barry, M; Cahill, J; Ledwidge, M; Maurer, B; McDonald, K; Ryan, E; Ryder, M; Timmons, L; Travers, B | 1 |
1 review(s) available for furosemide and perindopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for furosemide and perindopril
| Article | Year |
|---|---|
Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care?
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cost-Benefit Analysis; Decision Making; Digoxin; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Health Care Costs; Heart Failure; Hospitalization; Humans; Ireland; Length of Stay; Male; Middle Aged; Perindopril; Prospective Studies; Time Factors; Ventricular Dysfunction, Left | 2003 |
6 other study(ies) available for furosemide and perindopril
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Effects of angiotensin-converting enzyme inhibitors on urinary excretions: interactions with diuretics.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Drug Interactions; Furosemide; Humans; Indoles; Magnesium; Perindopril; Reference Values; Sodium; Uric Acid; Urine | 1992 |
Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Clonidine; Dihydralazine; Drug Therapy, Combination; Furosemide; Hydralazine; Hypertension, Renovascular; Indoles; Kidney; Male; Organ Size; Perindopril; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Time Factors | 1986 |
[Comparison of the cardiac, renal and endocrine effects of converting enzyme inhibition with those of a classical triple therapy in experimental renal hypertension].
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Volume; Clonidine; Dihydralazine; Drug Therapy, Combination; Furosemide; Heart Ventricles; Hydralazine; Hypertension, Renovascular; Kidney; Male; Organ Size; Perindopril; Rats; Rats, Inbred Strains; Renin-Angiotensin System | 1984 |